These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1665830)

  • 61. Angiotensin-II stimulates an increase in cAMP and expression of 17 alpha-hydroxylase cytochrome P450 in fetal bovine adrenocortical cells.
    Bird IM; Mason JI; Oka K; Rainey WE
    Endocrinology; 1993 Feb; 132(2):932-4. PubMed ID: 8381079
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists.
    Catalioto RM; Porchia R; Renzetti AR; Criscuoli M; Subissi A; Giachetti A
    Eur J Pharmacol; 1995 Jul; 280(3):285-92. PubMed ID: 8566096
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Angiotensins induce the release of prostacyclin from rabbit vas deferens: evidence for receptor heterogeneity.
    Catalioto RM; Renzetti AR; Criscuoli M; Mizrahi J; Subissi A
    Eur J Pharmacol; 1994 Apr; 256(1):93-7. PubMed ID: 8026565
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat.
    Cox SL; Story DF; Ziogas J
    Br J Pharmacol; 1996 Nov; 119(5):965-75. PubMed ID: 8922747
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of glucagon and glucagon-like peptide-1 on glucocorticoid secretion of dispersed rat adrenocortical cells.
    Andreis PG; Malendowicz LK; Neri G; Tortorella C; Nussdorfer GG
    Life Sci; 1999; 64(24):2187-97. PubMed ID: 10374908
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites.
    Cox SL; Ben A; Story DF; Ziogas J
    Br J Pharmacol; 1995 Mar; 114(5):1057-63. PubMed ID: 7780640
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacological characteristics of the positive inotropic effect of angiotensin II in the rabbit ventricular myocardium.
    Ishihata A; Endoh M
    Br J Pharmacol; 1993 Apr; 108(4):999-1005. PubMed ID: 8387388
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Angiotensin II receptor-mediated calcium influx in bovine adrenal glomerulosa cells.
    Ambroz C; Catt KJ
    Endocrinology; 1992 Jul; 131(1):408-14. PubMed ID: 1377126
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
    Morita O; Kushida H; Kunihara M
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of losartan potassium and deoxycorticosterone acetate on tail skin temperature response to acute administration of angiotensin II.
    Fregly MJ; Rowland NE
    Pharmacol Biochem Behav; 1992 Sep; 43(1):229-33. PubMed ID: 1472262
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vitro pharmacology of a novel non-peptide angiotensin II-receptor antagonist, E4177.
    Okunishi H; Song K; Oka Y; Kobayashi T; Kawamoto T; Ishihara H; Mori N; Miyazaki M
    Jpn J Pharmacol; 1993 Jul; 62(3):239-44. PubMed ID: 8411773
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors.
    Laredo J; Shah JR; Lu ZR; Hamilton BP; Hamlyn JM
    Hypertension; 1997 Jan; 29(1 Pt 2):401-7. PubMed ID: 9039134
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evidence that [Sar1]angiotensin II behaves differently from angiotensin II at angiotensin AT1 receptors in rabbit aorta.
    Liu YJ
    Eur J Pharmacol; 1993 Apr; 235(1):9-15. PubMed ID: 8519284
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
    Cazes M; Provost D; Versigny A; Cloarec A
    Eur J Pharmacol; 1995 Sep; 284(1-2):157-70. PubMed ID: 8549620
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Losartan: the first angiotensin receptor antagonist in clinical use.
    Beevers DG
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S1. PubMed ID: 8583475
    [No Abstract]   [Full Text] [Related]  

  • 76. Binding of angiotensin antagonists to rat liver and brain membranes measured ex vivo.
    Marshall FH; Clark SA; Michel AD; Barnes JC
    Br J Pharmacol; 1993 Jul; 109(3):760-4. PubMed ID: 8358571
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats.
    Tofovic SP; Pong AS; Jackson EK
    Hypertension; 1991 Dec; 18(6):774-82. PubMed ID: 1743758
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
    Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacological characterization of the contractile responses to angiotensin analogues in guinea-pig isolated longitudinal muscle of small intestine.
    Hawcock AB; Barnes JC
    Br J Pharmacol; 1993 Apr; 108(4):1150-5. PubMed ID: 8485624
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [125I]EXP985: a highly potent and specific nonpeptide radioligand antagonist for the AT1 angiotensin receptor.
    Chiu AT; McCall DE; Roscoe WA
    Biochem Biophys Res Commun; 1992 Nov; 188(3):1030-9. PubMed ID: 1445340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.